Sector: health
Conviction from: S&PCitrini
52-week range: 244.82377.54
Cencora, Inc. sources and distributes pharmaceutical products in the United States and internationally. The company's U.S.
1 tracked filer(s) hold this · 0 opened, 1 added, 0 trimmed in 30-JUN-2026
Aggregate 13FScore 42 — mean of 1 scored holder(s) · buyers (new/add) avg 42. Higher = the smart money in this name has the better track record.
| Filer | 13FScore | This quarter | Shares | Value | % of their book |
|---|
| Ancora | 42 | Added +6% | 4,608 | $1,304,101 | 0.0% |
Beyond 13F — activists, insiders, politicians & research
| Filed | Insider | Role | Shares | Value | |
|---|
| 2026-05-28 | DURCAN DERMOT MARK | director | 4,000 | $1,065,040 | Form 4 |
1 disclosed trade(s) by 1 filer(s).
7 disclosed trade(s) by 1 filer(s).
| Trade date | Who | Type | Amount | |
|---|
| 2026-07-01 | Trump, Donald J President | SELL | $100,001 - $250,000 | PTR |
| 2026-07-01 | Trump, Donald J President | SELL | $50,001 - $100,000 | PTR |
| 2026-07-01 | Trump, Donald J President | SELL | $1,001 - $15,000 | PTR |
| 2026-07-01 | Trump, Donald J President | SELL | $50,001 - $100,000 | PTR |
| 2026-07-01 | Trump, Donald J President | BUY | $50,001 - $100,000 | PTR |
| 2026-07-01 | Trump, Donald J President | BUY | $15,001 - $50,000 | PTR |
| 2026-07-01 | Trump, Donald J President | BUY | $1,001 - $15,000 | PTR |
| Report | Date | Stance |
|---|
| #94 — Thematic Primer: Artificial Intelligence, Phase 2 | 2025-04-23 | LONG |